Patent Issued for Methods for diagnosing, prognosing, and treating parkinson's disease or parkinsonism (USPTO 12012634).

Population Bio Inc. has been granted a patent for methods of diagnosing, prognosing, and treating Parkinson's disease or parkinsonism. The patent involves screening individuals for genetic variations associated with neurological disorders, such as Parkinson's disease, using various samples like blood, saliva, urine, serum, tears, skin, tissue, or hair. The presence of these genetic variations can indicate whether an individual has the neurological disorder or an increased susceptibility to it. The methods described in the patent utilize techniques like PCR, sequencing, and microarray analysis to detect and analyze the genetic variations. These methods have the potential to aid in the development of therapeutics and improve disease management for neurological disorders. The patent also includes methods for administering therapeutic agents based on specific genetic variations. The patent was filed by Peggy S. Eis and published in June 2024. [Extracted from the article]